Literature DB >> 12962784

Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil.

R Lauzurica1, B Bayés, C Frías, N Fontseré, A Hernandez, L Matas, A Jimenez, J Bonet, R Romero.   

Abstract

Disseminated varicella zoster virus (VZV) infection is a rare complication after renal transplantation in adults. We report 4 cases diagnosed in our transplant patients. One of which was a primary infection (chicken pox) with multivisceral involvement (hepatitis, pneumonitis, myocarditis, and disseminated intravascular coagulation). The other 3 patients VZV-seropositive before transplantation suffered from disseminated zoster. No immunosuppressive drug was significantly associated with a higher risk of disseminated VZV infection. However, from our experience, we believe that mycophenolate mofetil (MMF), plays a part in the clinical presentation of the disease. Early treatment with high doses of acyclovir is fundamental in infection control. It is essential to perform a pretransplantation serological VZV study on all patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962784     DOI: 10.1016/s0041-1345(03)00684-5

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  18 in total

Review 1.  Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.

Authors:  Martina Prelog; Jörn Schönlaub; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2010-11-15       Impact factor: 3.714

Review 2.  Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity.

Authors:  M L Ritter; L Pirofski
Journal:  Transpl Infect Dis       Date:  2009-05-26       Impact factor: 2.228

3.  Susceptibilities of several clinical varicella-zoster virus (VZV) isolates and drug-resistant VZV strains to bicyclic furano pyrimidine nucleosides.

Authors:  Graciela Andrei; Rebecca Sienaert; Chris McGuigan; Erik De Clercq; Jan Balzarini; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

4.  Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis.

Authors:  James F Howard; Vera Bril; Ted M Burns; Renato Mantegazza; Malgorzata Bilinska; Andrzej Szczudlik; Said Beydoun; Francisco Javier Rodriguez De Rivera Garrido; Fredrik Piehl; Mariarosa Rottoli; Philip Van Damme; Tuan Vu; Amelia Evoli; Miriam Freimer; Tahseen Mozaffar; E Sally Ward; Torsten Dreier; Peter Ulrichts; Katrien Verschueren; Antonio Guglietta; Hans de Haard; Nicolas Leupin; Jan J G M Verschuuren
Journal:  Neurology       Date:  2019-05-22       Impact factor: 9.910

Review 5.  Simultaneous Occurrence of Varicella Zoster Virus-Induced Pancreatitis and Hepatitis in a Renal Transplant Recipient: A Case Report and Review of Literature.

Authors:  Puneet Chhabra; Priyadarshi Ranjan; Deepak K Bhasin
Journal:  Perm J       Date:  2017-03-10

6.  VZV encephalitis following successful treatment of CMV infection in a patient with kidney transplant.

Authors:  Shahzaib Nabi; Pushpinderdeep Kahlon; Mariella Goggins; Anita Patel
Journal:  BMJ Case Rep       Date:  2014-12-02

Review 7.  Mycophenolate mofetil in the treatment of systemic lupus erythematosus.

Authors:  Ali Sahin
Journal:  Eurasian J Med       Date:  2009-12

8.  Varicella zoster virus (VZV) in solid organ transplant recipients.

Authors:  S A Pergam; A P Limaye
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

9.  Incidence and risk factors for herpes zoster following heart transplantation.

Authors:  S Koo; L S Gagne; P Lee; P P Pratibhu; L M James; M M Givertz; F M Marty
Journal:  Transpl Infect Dis       Date:  2013-10-23       Impact factor: 2.228

10.  Varicella zoster virus in solid organ transplantation.

Authors:  S A Pergam; A P Limaye
Journal:  Am J Transplant       Date:  2013-03       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.